
Breast cancer is the most prevalent zzso affecting women and ranks second in zzso deaths, in which death occurs primarily from zzso zzso zzso breast cancer zzso is a more aggressive and zzso zzso of breast cancer that is initially responsive to treatment of zzso agents zzso such as zzso Recently, we reported the characterization of AMG zzso an orally zzso zzso and highly selective zzso zzso inhibitor that is active in zzso cell zzso In this report, we investigate the activity of AMG 900 alone and in combination with two distinct classes of zzso zzso and zzso in zzso zzso cell lines and zzso In zzso cells, AMG 900 inhibited zzso of zzso zzso on zzso a zzso zzso of zzso and induced zzso and zzso Furthermore, AMG 900 zzso the zzso effects of zzso and zzso at low zzso zzso In mice, AMG 900 significantly inhibited the growth of zzso zzso zzso zzso zzso zzso zzso zzso and zzso zzso The combination of AMG 900 with zzso enhanced tumor zzso in zzso zzso zzso compared with either zzso zzso combining AMG 900 with zzso resulted in zzso of zzso zzso zzso zzso in which more than 50% of the tumors failed to zzso 75 days after the zzso of drug zzso These findings suggest that AMG zzso alone and in combination with zzso may be an effective intervention strategy for the treatment of zzso breast cancer and provide potential therapeutic options for patients with zzso zzso 

